Abstract
Objective. The purpose of this article is to describe the imaging biomarkers of treatment response and provide an overview of anatomic imaging biomarkers. Conclusion. Imaging biomarkers of treatment response have evolved into the primary endpoint of response in most phase 2 studies. Anatomic imaging biomarkers are appliedto depict change in tumor size in response to treatment and are currently the most commonly applied method of treatment response evaluation.
Original language | English (US) |
---|---|
Pages (from-to) | 237-245 |
Number of pages | 9 |
Journal | American Journal of Roentgenology |
Volume | 201 |
Issue number | 2 |
DOIs | |
State | Published - Aug 1 2013 |
Keywords
- Anatomic imaging biomarker
- Imaging biomarker
- RECIST
- Volumetric evaluation
- WHO guideline
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging